Category: Research

A new MRI technique that enables doctors to better visualise what the brain is doing could identify specific areas of a slow-growing brain tumour that may be becoming more aggressive. New findings by scientists at the Erasmus University in Rotterdam suggest that visualising the whole tumour may be critical to identifying key changes and where patients may need more active treatment.

If we can find a way to interrupt a cancer cell’s ability to keep dividing, we may have a key to stopping tumours growing. Researchers, Dr Wong and Dr Voon ,tells us about the discovery they made into a tumour’s ability to continuously divide.

Research we funded has added value to a clinical trial that started in 2004. Updated scientific techniques showed that some children with a medulloblastoma can safely be spared harmful treatments.

We hear from two clinical psychologists who are helping young people after their brain tumour treatments through our ACT NOW study.

New research shows that stem cells may be primed to activate. This early stage research could lead us to the reason glioblastomas recur so quickly.

The Brian Cross Memorial Trust will fund ‘Future Leader’ Dr Spencer Watson’s three year glioblastoma brain tumour research.

New ‘Tessa Jowell Centre of Excellence’ status recognises delivery of outstanding care and treatment by NHS staff in their efforts to provide above excellent patient care through a difficult time

The Brain Tumour Charity responds to trial suggesting cannabis-based drug could be combined with chemotherapy in recurrent glioblastomas

We are calling on the Prime Minister to protect charity funded research – and we need your help!

Our researchers from The Everest Centre have new results that show the drug trametinib can stop tumour growth in some children with low grade brain tumours, in some cases the tumour was seen to shrink as well.

Artificial intelligence (AI) may be the key to fast and consistent renal cell tumour diagnoses, all because of work we fund on brain tumours.

A new publication from one of our research projects shines a light on the differences between the cells in the middle/core of a glioblastoma (GBM) compared to the cells spreading/infiltrating into healthy brain around the tumour.

Dr Gelareh Zadeh is leading research in Canada which will help predict the risk of meningioma regrowth.

Many things are uncertain right now, but our commitment to research isn’t one of them.

The Brain Tumour Charity is curating and facilitating a series of 60-minute webinars for researchers. The webinars feature experts in the brain tumour field speaking on a wide range of current topics.

Researchers are pioneering a promising use of focused ultrasound against glioblastoma, an aggressive brain tumour.

Researchers have developed a new ‘liquid biopsy’ blood test to diagnose brain tumours, which could reduce the need for invasive procedures.

The human genome contains nearly 22,000 genes and various studies have explored the nearly 2% of DNA that creates proteins. Far less is known about the remaining 98% of DNA that does not encode protein.

A new machine learning approach can classify gliomas, a common type of brain tumour, into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access.

Australia is joining the clinical trial to test a new treatment in children with brain cancer. The trial will be led by Sydney Children’s Hospital.

Researcher Todd Hankinson and his team at Children’s Hospital Colorado have studied biological differences between paediatric and adult ACP tumours

COVID-19 has dramatically transformed the research landscape for our community but we remain driven to accelerate new treatments.

Researcher Till Milde and his team from the Hopp Children’s Cancer Center Heidelberg (KiTZ) have developed a new test system.

The NIHR announced yesterday that they have published a framework for restarting research activities that have a been paused as a result of Covid-19.